Antithrombotic Coatings
What Is an Antithrombotic Coating?
An antithrombotic coating is a surface treatment applied to a medical device to help reduce unwanted blood-material interactions that can contribute to thrombus formation. These coatings are commonly considered for blood-contacting devices such as vascular implants, catheters, stents, grafts, filters, and other devices exposed to circulating blood.
When a medical device contacts blood, the surface can interact with plasma proteins, platelets, red blood cells, white blood cells, and components of the coagulation and complement systems. These interactions can begin rapidly after exposure. Depending on the device, material, surface condition, flow environment, and clinical use case, these interactions may contribute to protein deposition, platelet adhesion, thrombin generation, fibrin formation, or clot accumulation.
Antithrombotic coatings are designed to improve the blood-contacting interface by modifying the surface properties of the device. Different coating technologies use different mechanisms. Some are intended to reduce protein adsorption, some incorporate biologically active agents, and others create passive surfaces that are less prone to platelet and fibrin accumulation.
Why Antithrombotic Coatings Are Used
Blood-contacting devices often operate in complex flow environments. Even small changes in surface roughness, material chemistry, device geometry, or local flow patterns can influence thrombus formation. Antithrombotic coatings may be considered when a device design requires improved blood compatibility, especially when the device includes foreign materials, porous structures, exposed metallic surfaces, polymeric components, or regions of disturbed flow.
Common reasons device developers evaluate antithrombotic coatings include:
Reducing platelet adhesion and activation
Limiting fibrin accumulation
Improving acute hemocompatibility in bench testing
Supporting development of vascular implants and catheter-based devices
Comparing coated and uncoated versions of a device during feasibility testing
Improving the blood-contacting surface of complex device geometries
Types of Antithrombotic Coating Approaches
Antithrombotic coatings can be broadly grouped into several categories:
Passive surface-modifying coatings
These coatings are intended to create a more blood-compatible interface without relying on a drug-eluting or actively released compound.
Heparin-based coatings
These coatings use heparin or heparin-like chemistry to influence coagulation-related interactions at the device surface.
Hydrophilic coatings
Some hydrophilic surfaces are used to reduce friction, improve lubricity, or modify protein interactions.
Drug-eluting or bioactive coatings
Some coatings incorporate active pharmaceutical or biological agents intended to influence local biological response.
Polymer thin-film coatings
Thin polymer coatings may be used to modify the outermost surface chemistry while minimizing changes to device geometry or mechanical performance.
Antithrombotic Coating Evaluation
A coating cannot be evaluated based on chemistry alone. Developers typically need to consider both coating performance and device-specific biological response. Testing may include coating thickness, coating coverage, adhesion, durability, particulate generation, surface characterization, and hemocompatibility endpoints.
For blood-contacting devices, hemocompatibility evaluation may include assessments related to thrombosis, coagulation, platelet response, hemolysis, complement activation, and hematology parameters. The appropriate test strategy depends on the device type, duration of blood contact, clinical use, and regulatory pathway.
How Alta Biomed Supports Antithrombotic Coating Development
Alta Biomed specializes in PzF coating technology and hemocompatibility testing support for blood-contacting medical devices. Our team works with device developers to evaluate coating feasibility, coating application methods, surface compatibility, coating integrity, and blood-contacting device performance in preclinical bench models such as in vitro human blood flow loops.
We support early feasibility through development-stage evaluations for devices such as vascular implants, heart valves, stents, grafts, shunts, catheter-based devices, filters, and other blood-contacting technologies.
Interested In Evaluating a Coating for Your Device
Contact Alta Biomed to discuss coating feasibility and hemocompatibility testing options.
6070 Corte Del Cedro, Unit A
Carlsbad, CA 92011